238 related articles for article (PubMed ID: 31669893)
21. Cholestasis induced by total parenteral nutrition.
Guglielmi FW; Regano N; Mazzuoli S; Fregnan S; Leogrande G; Guglielmi A; Merli M; Pironi L; Penco JM; Francavilla A
Clin Liver Dis; 2008 Feb; 12(1):97-110, viii. PubMed ID: 18242499
[TBL] [Abstract][Full Text] [Related]
22. Clinical Features of Liver Injury Induced by Immune Checkpoint Inhibitors in Japanese Patients.
Imoto K; Kohjima M; Hioki T; Kurashige T; Kurokawa M; Tashiro S; Suzuki H; Kuwano A; Tanaka M; Okada S; Kato M; Ogawa Y
Can J Gastroenterol Hepatol; 2019; 2019():6391712. PubMed ID: 31929981
[TBL] [Abstract][Full Text] [Related]
23. Utility of liver biopsy in the evaluation of pediatric total parenteral nutrition cholestasis.
Buonpane CL; Ares GJ; Englert EG; Helenowski I; Cohran VC; Hunter CJ
Am J Surg; 2018 Oct; 216(4):672-677. PubMed ID: 30041734
[TBL] [Abstract][Full Text] [Related]
24. Total parenteral nutrition-associated cholestasis in infants: clinical and liver histologic studies.
Chou YH; Yau KI; Hsu HC; Chang MH
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1993; 34(4):264-71. PubMed ID: 8213156
[TBL] [Abstract][Full Text] [Related]
25. Atypical causes of cholestasis.
Nguyen KD; Sundaram V; Ayoub WS
World J Gastroenterol; 2014 Jul; 20(28):9418-26. PubMed ID: 25071336
[TBL] [Abstract][Full Text] [Related]
26. The hepatobiliary complications of malnutrition and nutritional support in adults.
McNeice A; Scott R; Rafferty GP; Cash WJ; Turner GB
Ir J Med Sci; 2019 Feb; 188(1):109-117. PubMed ID: 29850987
[TBL] [Abstract][Full Text] [Related]
27. The Role of Parenteral Lipids in the Development of Hepatic Dysfunction and Hepatic Steatosis in a Mouse Model of Total Parenteral Nutrition.
Xu Z; Sun Y
J Nutr Sci Vitaminol (Tokyo); 2019; 65(1):24-30. PubMed ID: 30814408
[TBL] [Abstract][Full Text] [Related]
28. Iatrogenic hepatic injury.
Rubin E
Hum Pathol; 1980 Jul; 11(4):312-31. PubMed ID: 6250973
[TBL] [Abstract][Full Text] [Related]
29. A case report of a challenging diagnosis of biliary atresia in a patient receiving total parenteral nutrition.
Agawu A; Wehrman A; Pogoriler J; Terry NA; Lin HC
BMC Pediatr; 2019 Mar; 19(1):72. PubMed ID: 30849955
[TBL] [Abstract][Full Text] [Related]
30. [Fish oil in prolonged parenteral nutrition in children--omega-3-fatty acids have a beneficial effect on the liver].
Strijbosch RA; van den Hoonaard TL; Olieman JF; Escher JC; Alwayn IP; Meijers-Ijsselstijn H
Ned Tijdschr Geneeskd; 2010; 154():A2003. PubMed ID: 20977797
[TBL] [Abstract][Full Text] [Related]
31. Total parenteral nutrition-induced steatosis: reversal by parenteral lipid infusion.
Reif S; Tano M; Oliverio R; Young C; Rossi T
JPEN J Parenter Enteral Nutr; 1991; 15(1):102-4. PubMed ID: 1901098
[TBL] [Abstract][Full Text] [Related]
32. Identification of Specific MicroRNA Biomarkers in Early Stages of Hepatocellular Injury, Cholestasis, and Steatosis in Rats.
Kagawa T; Shirai Y; Oda S; Yokoi T
Toxicol Sci; 2018 Nov; 166(1):228-239. PubMed ID: 30125006
[TBL] [Abstract][Full Text] [Related]
33. Total Parenteral Nutrition-Induced Cholestasis: Prevention and Management.
Beath SV; Kelly DA
Clin Liver Dis; 2016 Feb; 20(1):159-76. PubMed ID: 26593297
[TBL] [Abstract][Full Text] [Related]
34. Ipilimumab-associated Hepatitis: Clinicopathologic Characterization in a Series of 11 Cases.
Johncilla M; Misdraji J; Pratt DS; Agoston AT; Lauwers GY; Srivastava A; Doyle LA
Am J Surg Pathol; 2015 Aug; 39(8):1075-84. PubMed ID: 26034866
[TBL] [Abstract][Full Text] [Related]
35. Assessment of Intestinal Failure Associated Liver Disease according to different diagnostic criteria.
Sasdelli AS; Agostini F; Pazzeschi C; Guidetti M; Lal S; Pironi L
Clin Nutr; 2019 Jun; 38(3):1198-1205. PubMed ID: 29778510
[TBL] [Abstract][Full Text] [Related]
36. Phytosterols, Lipid Administration, and Liver Disease During Parenteral Nutrition.
Zaloga GP
JPEN J Parenter Enteral Nutr; 2015 Sep; 39(1 Suppl):39S-60S. PubMed ID: 26177665
[TBL] [Abstract][Full Text] [Related]
37. Preventing parenteral nutrition liver disease.
Kelly DA
Early Hum Dev; 2010 Nov; 86(11):683-7. PubMed ID: 20923719
[TBL] [Abstract][Full Text] [Related]
38. Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations.
Kleiner DE; Chalasani NP; Lee WM; Fontana RJ; Bonkovsky HL; Watkins PB; Hayashi PH; Davern TJ; Navarro V; Reddy R; Talwalkar JA; Stolz A; Gu J; Barnhart H; Hoofnagle JH;
Hepatology; 2014 Feb; 59(2):661-70. PubMed ID: 24037963
[TBL] [Abstract][Full Text] [Related]
39. Frequency and pathological characteristics of drug-induced liver injury in a tertiary medical center.
Ettel M; Gonzalez GA; Gera S; Eze O; Sigal S; Park JS; Xu R
Hum Pathol; 2017 Oct; 68():92-98. PubMed ID: 28873351
[TBL] [Abstract][Full Text] [Related]
40. Immune checkpoint inhibitor-induced gastrointestinal and hepatic injury: pathologists' perspective.
Karamchandani DM; Chetty R
J Clin Pathol; 2018 Aug; 71(8):665-671. PubMed ID: 29703758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
